Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000940797 | SCV001086664 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000940797 | SCV002811832 | likely benign | Polyglandular autoimmune syndrome, type 1 | 2021-07-02 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000940797 | SCV001460096 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004754641 | SCV005359673 | likely benign | AIRE-related disorder | 2024-09-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |